Pharma CEO raises EpiPen price by 400%, and gets a 671% raise

Originally published at: http://boingboing.net/2016/08/23/pharma-ceo-raises-epipen-price.html

3 Likes

Between this and Shkreli, how many more datapoints do we need before the line spells out “Pharma CEOs are sociopathic”?

43 Likes

Dealing with our outstanding medical system with a family member right now. The whole system stinks like a kettle of rotten fish. Not a damn thing surprises me anymore when it comes to profiteering off the weak or vulnerable.

35 Likes

Very good, Padawan. You have learned well.

20 Likes

Yeah, this was his take:

“Mylan is the good guy. They had one product, and they finally started making a little bit of money and everyone is going crazy over it,” said Shkreli. “Like I said, it’s $300 a pack. $300. My iPhone is $700. … It’s $300 and 90 percent of Americans are insured.”

But so was this…?

These guys are really vultures. What drives this company’s moral compass?

8 Likes

Fun fact! Mylan Pharmaceuticals CEO Heather Bresch is also the daughter of West Virginia governor (now Senator) Joe Manchin and got her MBA at West Virginia University even though she did not have enough academic credits. When the scandal was uncovered, the president of WVU was forced to resign.

39 Likes

First against the wall, if Americans actually had the stones for another revolution.

21 Likes

From each according to their need, to each according to their ruthlessness.

16 Likes

Deja vu…

8 Likes

The price hikes are one scandal, but the other is her pay. She makes more in a day than I make in a year. What could she possibly be doing that makes her time SO VERY VALUABLE?

23 Likes

Could you make decisions that so directly kill children to enrich your shareholders?

Evil is her value.

35 Likes

Real Americans will stand up for her, because they know that in this land of opportunity they too could someday be a millionaire pharma CEO.

26 Likes

Fucking disgustipating.

ETA: To hell with your bandwidth. I’m fucking livid right now.

32 Likes

See, women executives can be as ruthless and heartless as anyone else.

14 Likes

The CEO is the daughter of Sen Joe Manchin. Funny how Congress hasn’t moved on the issue of pharmagouging.

She’s also notable for her dad getting her state college to issue her an MBA without having the credits to graduate.

13 Likes

People people people!

We’re all focusing on the obvious price gouging on a pharmaceutical item that people with severe anaphylactic reactions quite literally need to save their lives…

I’m sure that there are plenty of other unethical and unscrupulous decisions and price points set by this CEO and company. Spread the love!

9 Likes

I live in New Zealand, and they go for up to NZD 180 (around USD 130) here, and that’s considered too expensive. The cost in the U.S. is mind-blowing.

10 Likes

The Gizmondo article is interesting. Like lobbying to get pens in schools, as well as making it standard it comes in a 2 pack.

3 Likes

How is Mylan protecting the “rights” to sell Epipens? I did a very quick google for epipen patents and found a drugpatentwatch.com site that claims epipens are protected by patents from 1987. Don’t they expire in 17 years? Wouldn’t that mean these are off patent?

Maybe I’m naive, but I would think a $250 Epipen would attract a generic competitor who could make a handsome profit for a much lower price.

6 Likes

There have been 2 attempts at generics according to the Gizmondo article, and one was recalled, and the other didn’t get FDA approval, though they are trying again next year.

5 Likes